Clinical Trials Logo

Filter by:
NCT ID: NCT04201158 Completed - Healthy Clinical Trials

A Comparison of Activities of Daily Living, Physical Fitness and Quality of Life in Obese and Healthy Adolescents

Start date: June 15, 2019
Phase:
Study type: Observational [Patient Registry]

It is known that activities of daily living, physical fitness, exercise capacity and quality of life are affected by the obesity. It is aimed to determine the effects obesity on daily living activities, physical fitness, exercise capacity and quality of life in obese adolescents compared to healthy subjects in this study. The relationship between these parameters and the activities of daily living which are less studied in obese adolescents will be evaluated.

NCT ID: NCT04200924 Completed - Balance Clinical Trials

Evaluation of Postural Control in Children With Idiopathic Toe Walking

Start date: June 1, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to evaluate postural control in children with idiopathic toe walking using computerized dynamic posturography (Biodex Balance System), which is reported to be a reliable and valid instrument for detecting changes in balance and postural control in the literature.

NCT ID: NCT04200885 Completed - Third Molar Surgery Clinical Trials

Is Therapeutic Elastic Bandage As Effective As Corticosteroids Following Third Molar Surgery?

Start date: May 2, 2019
Phase: Phase 4
Study type: Interventional

In this study; Among the patients randomized because of severe postoperative sequelae expected as a result of radiological and clinical examinations; nonsteroid antiinflammatory drug prescribed group compared with preoperative single dose intraoral submucosal corticosteroid administration and therapeutic elastic bandage application considering inflammatory symptoms' severity and health related quality of life following surgical removal of impacted third molars. The study hypothesis was formed stating that corticosteroid injection and elastic bandage application would reduce the inflammatory symptoms more than NSAID.

NCT ID: NCT04200222 Completed - Preeclampsia Clinical Trials

Vanadium in Late-onset Preeclampsia

Vanadium PE
Start date: March 1, 2018
Phase:
Study type: Observational

Introduction: Cadmium, lead and vanadium important pollutants produced from anthropogenic activities, has been suggested to be embryotoxic and fetotoxic in a lot of studies. However, the causes of preeclampsia are little known and heavy metals merit further investigation. We tested whether late-onset preeclampsia (L-PrE) was associated with exposure to these metals. Methods: This study was designed to determine maternal plasma cadmium, lead and vanadium concentrations in women with L-PrE (n=46) compared to those of normotensive women (n=46). These three heavy metals concentrations measured using inductively coupled plasma-mass spectrometry were compared.

NCT ID: NCT04200053 Completed - Burn Degree Second Clinical Trials

The Effect of Reflexology Massage and Passive Music Therapy Intervention Before Burn Dressing

Start date: August 12, 2019
Phase: N/A
Study type: Interventional

Reflexology massage applied before burn dressing reduces pain, anxiety and sleep problems

NCT ID: NCT04199988 Recruiting - Healthy Clinical Trials

Reliability of Posterior Shoulder Endurance Test in Overhead Athletes

Start date: December 31, 2019
Phase:
Study type: Observational

The purpose of this study was to investigate the reliability of posterior shoulder endurance test in overhead athletes and to compare the endurance of posterior shoulder muscles between athletes with and without shoulder pain.

NCT ID: NCT04199546 Completed - Swallowing Disorder Clinical Trials

Chewing and Swallowing Training Program in Coffin-Lowry Syndrome

Start date: December 12, 2019
Phase: N/A
Study type: Interventional

This study will report the chewing and swallowing disorders of a Coffin-Lowry Syndrome (CLS) patient, and effects of chewing and swallowing training on chewing and swallowing function.

NCT ID: NCT04199507 Completed - Autism Clinical Trials

Physical Fitness in Autism

Start date: December 16, 2019
Phase:
Study type: Observational

Although there are some studies investigating the physical activity levels of children with autism in the literature, no comprehensive study investigating the relationship between posture and physical fitness parameters, family anxiety level and quality of life of individuals with autism who have continued physical activity program has not been found. The aim of our study is to compare postural disorders and physical fitness parameters, family anxiety level and quality of life between individuals with autism and healthy individuals attending physical activity program.

NCT ID: NCT04199338 Enrolling by invitation - Self Efficacy Clinical Trials

The Effect of Web Based Education Based on Self-Care Deficiency Theory on Self-Care Power and Self-Efficacy and Perceived Social Support in Patients Receiving Peritoneal Dialysis

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Web-based training based on the Self-Care Deficiency Theory has an effect on increasing self-care in in patients undergoing peritoneal dialysis. Web-based training based on Self-Care Deficiency Theory has an effect on increasing self-efficacy in patients undergoing peritoneal dialysis. Web-based education based on Self-Care Deficiency Theory has an effect on increasing perceived social support level in patients undergoing peritoneal dialysis.

NCT ID: NCT04199104 Active, not recruiting - Clinical trials for Head and Neck Squamous Cell Carcinoma

A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)

LEAP-10
Start date: February 5, 2020
Phase: Phase 3
Study type: Interventional

This is a study of pembrolizumab (MK-3475) with or without lenvatinib (E7080/MK-7902) as a first line intervention in a PD-L1 selected population with participants with recurrent or metastatic head and neck squamous cell carcinoma. Hypotheses include: - Pembrolizumab + lenvatinib is superior to pembrolizumab + placebo with respect to Objective Response Rate (ORR) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) by blinded independent central review (BICR). - Pembrolizumab + lenvatinib is superior to pembrolizumab + placebo with respect to Progression Free Survival (PFS) per RECIST 1.1 as assessed by BICR. - Pembrolizumab + lenvatinib is superior to pembrolizumab + placebo with respect to overall survival (OS).